Winthrop Pharmaceuticals Private Limited
About Winthrop Pharmaceuticals Private Limited
Data last updated:
Winthrop Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the retail trading segment of the trading and commerce sector. It was incorporated on 22 July 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24100DL2015PTC283072. Its GSTIN is 07AABCW6818L2ZV (Delhi). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ashutosh Kumar and Nitu Sah.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D – 40 D Block Mandawali Unchepar, Delhi, India – 110092.
As per the financials filed for FY 2024, the company reported a revenue of ₹9.48 Lakh, a decline of 29% compared to the previous year. For the same year it recorded a net profit of ₹982 (net margin 0.1%) and EBITDA of ₹7,559 (EBITDA margin 0.8%). Revenue has grown at a compounded annual rate (CAGR) of 24% over three years and 16% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Winthrop Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressD – 40 D Block Mandawali Unchepar, Delhi, India – 110092
- IndustryTrading, Retail Trading, Retailers
To see the full contact details of Winthrop Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Winthrop Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Winthrop Pharmaceuticals Private Limited, buy the company report.
Financials of Winthrop Pharmaceuticals Private Limited
FY 2025 filings availableWinthrop Pharmaceuticals Private Limited reported revenue of ₹9.48 Lakh (down 29% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 29% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 16%. EBITDA rose 113% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7,559 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹982 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.8% | ||||
| Net Profit Margin | 0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Winthrop Pharmaceuticals Private Limited, buy the company report.
Board of directors of Winthrop Pharmaceuticals Private Limited
Winthrop Pharmaceuticals has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ashutosh Kumar | Director | 13 Mar 2020 | 6 Years 7 Months | Current |
| Nitu Sah Also directs: Beveri Beverage and Foods Private Limited | Director | 16 Nov 2024 | 1 Years 11 Months | Current |
Peer comparison
Winthrop Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vida Pharmaceuticals Private Limited | ₹9.57 Lakh (FY 2016) | 32.0% | Kolkata, West Bengal, India | |||
| Lotsun Pharmaceuticals (OPC) Private Limited | ₹9.57 Lakh (FY 2025) | 15.0% | Motihari, Bihar, India | |||
| Attic Pharmaceuticals Private Limited | ₹9.56 Lakh (FY 2025) | 91.0% | Patna, Bihar, India | |||
| Winthrop Pharmaceuticals Private Limitedthis company | ₹9.48 Lakh (FY 2024) | ₹982 | 0.1% | -29.0% | Delhi, India | |
| Holid Pharmaceuticals Private Limited | ₹9.44 Lakh (FY 2025) | 29.0% | Karnal, Haryana, India |
To see the full peer comparison of Winthrop Pharmaceuticals Private Limited, buy the company report.
Auditor
Winthrop Pharmaceuticals Private Limited is audited by JAI SINGH for the financial year 2016.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| JAI SINGH | FY 2016 | 525477 |
Shareholding
The shareholding of Winthrop Pharmaceuticals Private Limited is on record for FY 2016, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2016 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Winthrop Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Winthrop Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Winthrop Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Winthrop Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AABCW6818L2ZV | Delhi | Active | 11 Jun 2018 |
To see the full GST registrations and return filing status of Winthrop Pharmaceuticals Private Limited, buy the company report.
Recent activity
Winthrop Pharmaceuticals Private Limited has 8 board changes on record since 2018: 2 appointments and 6 cessations. The latest: Nitu Sah was appointed as Director on 16 Nov 2024.
Frequently asked questions
Winthrop Pharmaceuticals is an active private limited company based in Delhi, India. The company works in retail trading, within the trading industry. It was incorporated on 22 July 2015 (11+ years old) and is registered under CIN U24100DL2015PTC283072.
Winthrop Pharmaceuticals has 2 current directors:
- Ashutosh Kumar - Director
- Nitu Sah - Director
The latest financial statements of Winthrop Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Winthrop Pharmaceuticals is 07AABCW6818L2ZV, registered in Delhi. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Winthrop Pharmaceuticals is U24100DL2015PTC283072. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Winthrop Pharmaceuticals was incorporated on 22 July 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Winthrop Pharmaceuticals by revenue are Vida Pharmaceuticals Private Limited, Lotsun Pharmaceuticals (OPC) Private Limited, Attic Pharmaceuticals Private Limited, Holid Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Nitu Sah was appointed as Director on 16 Nov 2024. Sushil Kumar ceased to be Director on 16 Nov 2024. Ashutosh Kumar was appointed as Director on 13 Mar 2020. Winthrop Pharmaceuticals has 8 board changes on record in total.
The registered office of Winthrop Pharmaceuticals is at D – 40 D Block Mandawali Unchepar, Delhi, India – 110092.
Winthrop Pharmaceuticals operates in the trading industry, in the retail trading segment.
The compliance status of Winthrop Pharmaceuticals is compliant as of 06 September 2026. The company is actively filing with the Registrar of Companies.